View Older Stories
-
Five earnings winners lead Friday's premarket surge
-
After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
-
Doximity, Inc. (DOCS) Misses Q1 EPS by 1c, Revenue Beats, Offers Guidance
-
Doximity, Inc. (DOCS) 6800 contracts of August 22.50 calls trade share price up 4.2%
-
OpenEvidence reaches $300m revenue run rate, Bank of America says
-
BofA Securities Double Downgrades Doximity Inc (DOCS) to Underperform
-
Doximity Inc (DOCS) PT Lowered to $38 at BofA Securities
-
Doximity, Inc. (DOCS) call put ratio 1 call to 2.7 puts
-
Increasing unusual put option volume: DOCS EXE AR POET UROY FCEL INOD CRVS WYFI AAOX
-
Doximity Inc (DOCS) PT Lowered at BMO Capital Amid 'Macro Challenges and AI Investment'
-
Piper Sandler on Doximity Inc (DOCS): 'Buyers'
-
Doximity Inc (DOCS) PT Lowered to $26 at Mizuho
-
Doximity Inc (DOCS) PT Lowered to $30 at Canaccord
-
Raymond James Downgrades Doximity Inc (DOCS) to Outperform, 'Valuation Case Still Attractive'
-
BTIG Downgrades Doximity Inc (DOCS) to Neutral
-
Doximity Inc (DOCS) PT Lowered to $19 at Evercore ISI
-
Doximity Inc (DOCS) PT Lowered to $27 at Needham
-
Doximity Inc (DOCS) PT Lowered to $19 at Truist Securities
-
Baird Downgrades Doximity Inc (DOCS) to Neutral
-
Jefferies Downgrades Doximity Inc (DOCS) to Hold
-
KeyBanc Downgrades Doximity Inc (DOCS) to Sector Weight
-
Wells Fargo Downgrades Doximity Inc (DOCS) to Equal Weight
-
After-hours movers: CSCO, HPE, DOCS, STUB, STAA, GO
-
Doximity integrates AI tools with Aledade's care platform
-
Doximity, Inc. (DOCS) Misses Q4 EPS by 2c, Beats on Revenue; Offers FY26 Revenue Guidance
-
BTIG highlights key trends from Boston Digital Health Summit
-
Raymond James on Doximity Inc (DOCS): 'We don’t view the news positively'
-
Raymond James Reiterates Strong Buy Rating on Doximity Inc (DOCS)
-
Doximity Inc (DOCS) PT Raised to $34 at Leerink Partners
-
Truist Securities Downgrades Doximity Inc (DOCS) to Hold
-
Doximity Inc (DOCS) PT Lowered to $47 at BofA Securities, 'Some incremental positives against market concerns'
-
Evercore ISI Downgrades Doximity Inc (DOCS) to In Line
-
Freedom Capital Markets Starts Doximity Inc (DOCS) at Buy
-
Doximity Inc (DOCS) PT Raised to $42 at Piper Sandler
-
Which healthcare stocks are at risk from AI and which to buy
-
Doximity Inc (DOCS) PT Lowered to $34 at Mizuho
-
Canaccord Genuity Upgrades Doximity Inc (DOCS) to Buy
-
Canaccord Genuity Upgrades Doximity Inc (DOCS) to Buy
-
Investor overreaction is a buying opportunity in this MedTech stock: Morgan Stanley
-
Doximity Inc (DOCS) PT Lowered to $25 at BMO Capital Amid Near-Term Headwinds
-
Doximity Inc (DOCS) PT Lowered to $37 at Truist Securities
-
Doximity Inc (DOCS) PT Lowered to $55 at Needham
-
Doximity Inc (DOCS) PT Lowered to $40 at Piper Sandler
-
JPMorgan Upgrades Doximity Inc (DOCS) to Neutral
-
After-hours movers: Amazon, Roblox, Bloom Energy, Reddit, Molina Health and more
-
Doximity, Inc. (DOCS) Tops Q3 EPS by 1c, Beats on Revenue; Offers FY26 Revenue Guidance
-
Doximity Inc (DOCS) PT Lowered to $70 at BofA Securities
-
Goldman Sachs Upgrades Doximity Inc (DOCS) to Buy
-
Raymond James on Doximity Inc (DOCS): 'We likely aren’t done with the competitive dynamic narrative'
-
RBC Capital Starts Doximity Inc (DOCS) at Outperform

